Evidence map›Paper›PMID 37570251›Full record

ArticleAnimals : an open access journal from MDPI2023

Antimicrobial Activity of Peptides Produced by

Fernando M M Sanca, Iago R Blanco, Meriellen Dias, Andrea M Moreno, Simone M M K Martins, Marco A Stephano, Maria A Mendes, Carlos M N Mendonça, Wellison A Pereira, Pamela O S Azevedo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Innovations in process engineering approaches for enhanced bacteriocin production.Journal of industrial microbiology & biotechnology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Biomolecule-Producing Probiotic BacteriumJournal of functional biomaterials · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Fernando M M SancaDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0009-0000-1543-5312
Iago R BlancoDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.
Meriellen DiasDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0002-2600-4582
Andrea M MorenoDepartment of Preventive Veterinary Medicine and Animal Health, School of Veterinary Medicine and Animal Sciences, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-3290-566X
Simone M M K MartinsDepartment of Animal Sciences, Faculty of Animal Sciences and Food Engineering, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-5895-3678
Marco A StephanoImmunobiological and Biopharmaceutical Laboratory, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0003-2927-0584
Maria A MendesDempster Mass Spectrometry Laboratory, Chemical Engineering Department, Polytechnic School, University of São Paulo, São Paulo 05508-000, Brazil.ORCID 0000-0002-2078-9286
Carlos M N MendonçaDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0002-0222-0862
Wellison A PereiraDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0002-7002-0811
Pamela O S AzevedoDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0002-9904-5254
Martin GierusInstitute of Animal Nutrition, Livestock Products, and Nutrition Physiology (TTE), Department of Agrobiotechnology, IFA-Tulln, University of Natural Resources and Life Sciences, 1190 Vienna, Austria.ORCID 0000-0001-6909-0356
Ricardo P S OliveiraDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.ORCID 0000-0001-8590-804X
Universidade de São Paulo · BRBOKU University · AT

Funding

National Council for Scientific and Technological Development 312923/2020-1São Paulo Research Foundation 2018/25511-1
6 · The paper itself

Abstract

Swine production is of great importance worldwide and has huge economic and commercial impact. Due to problems with bacterial infection, the use of antimicrobials has increased in the last decades, particularly in Latin America and Asia. This has led to concerns about antimicrobial resistance, which poses risks to human health and the environment. The use of probiotic organisms has been proposed as an alternative to this use, as these beneficial bacteria can produce antimicrobial peptides, such as bacteriocins, which allow the induction of inhibitory effects against pathogenic microorganisms. Among probiotics, some bacteria stand out with the inhibition of animal pathogens. The bacteriocin-like inhibitory substances (BLISs) of

Indexed as

bacteriocinlactic acid bacteriaLactococcus lactispeptidespig

Identifiers

PMID37570251
PMCPMC10416947
OpenAlexW4385350545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.